Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
NCT05916261
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Advanced Pancreatic Cancer
Interventions
BIOLOGICAL:
Personalized neoantigen tumor vaccine
Sponsor
Ruijin Hospital